| scholarly article | Q13442814 |
| P356 | DOI | 10.1021/JM701093Y |
| P698 | PubMed publication ID | 18220330 |
| P2093 | author name string | Deborah E Shalev | |
| Carrie Haskell-Luevano | |||
| Efrat Halbfinger | |||
| Amnon Hoffman | |||
| Chaim Gilon | |||
| Zhimin Xiang | |||
| Avi Swed | |||
| Tair Lapidot | |||
| Shmuel Hess | |||
| Ilan Winkler | |||
| Oded Ovadia | |||
| Federico P Portillo | |||
| Yael Gabinet | |||
| Eli Safrai | |||
| Yaniv Linde | |||
| Avi Faier | |||
| Dana Yarden | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | obesity | Q12174 |
| D-(-)-mannitol | Q407646 | ||
| P304 | page(s) | 1026-1034 | |
| P577 | publication date | 2008-01-26 | |
| P1433 | published in | Journal of Medicinal Chemistry | Q900316 |
| P1476 | title | Backbone cyclic peptidomimetic melanocortin-4 receptor agonist as a novel orally administrated drug lead for treating obesity | |
| P478 | volume | 51 |
| Q39211934 | Bench-top to clinical therapies: A review of melanocortin ligands from 1954 to 2016. |
| Q47606774 | Click-Chemistry-Mediated Synthesis of Selective Melanocortin Receptor 4 Agonists. |
| Q88719341 | Conversion of Protein Active Regions into Peptidomimetic Therapeutic Leads Using Backbone Cyclization and Cycloscan - How to Do it Yourself! |
| Q88719333 | Cyclic Peptides that Govern Signal Transduction Pathways: From Prokaryotes to Multi-Cellular Organisms |
| Q33727544 | Cyclic peptide inhibitors of HIV-1 integrase derived from the LEDGF/p75 protein |
| Q42936371 | EPSA: A Novel Supercritical Fluid Chromatography Technique Enabling the Design of Permeable Cyclic Peptides. |
| Q27026287 | Genetic and epigenetic control of metabolic health |
| Q27021652 | Getting in shape: controlling peptide bioactivity and bioavailability using conformational constraints |
| Q38028559 | Improvement of drug-like properties of peptides: the somatostatin paradigm |
| Q34735557 | In silico study on binding specificity of gonadotropins and their receptors: design of a novel and selective peptidomimetic for human follicle stimulating hormone receptor. |
| Q42660235 | Incorporation of a bioactive reverse-turn heterocycle into a peptide template using solid-phase synthesis to probe melanocortin receptor selectivity and ligand conformations by 2D 1H NMR. |
| Q38658728 | Novel approaches to the design of bioavailable melanotropins. |
| Q47290007 | Optical imaging of the rat brain suggests a previously missing link between top-down and bottom-up nervous system function |
| Q64227581 | Peptides and Peptidomimetics as Potential Antiobesity Agents: Overview of Current Status |
| Q38618616 | Rational, computer-enabled peptide drug design: principles, methods, applications and future directions. |
| Q38533393 | Review backbone N-modified peptides: How to meet the challenge of secondary amine acylation |
| Q38264736 | Strategic approaches to optimizing peptide ADME properties |
| Q33355086 | Structure-activity relationship and metabolic stability studies of backbone cyclization and N-methylation of melanocortin peptides |
| Q86186199 | Structure-activity relationships of peptides incorporating a bioactive reverse-turn heterocycle at the melanocortin receptors: identification of a 5800-fold mouse melanocortin-3 receptor (mMC3R) selective antagonist/partial agonist versus the mouse |
| Q83417203 | Synthesis of N-methylated cyclic peptides |
| Q42844150 | Synthesis of peptide macrocycles using unprotected amino aldehydes |
| Q34343356 | Synthesis, biophysical, and pharmacological evaluation of the melanocortin agonist AST3-88: modifications of peptide backbone at Trp 7 position lead to a potent, selective, and stable ligand of the melanocortin 4 receptor (MC4R). |
| Q38115094 | The melanocortin-4 receptor as target for obesity treatment: a systematic review of emerging pharmacological therapeutic options |
| Q37855887 | Using peptides to study protein-protein interactions |
Search more.